As an early adopter of IV automation technology to support in-house sterile compounding, Cone Health originally implemented Omnicell’s IV Compounding Service (IVCS) with two i.v.STATION robots in 2019. Following impressive initial results, including enhanced IV compounding accuracy and a stabilized supply of ready-to-administer (RTA) drugs, Cone Health added a third i.v.STATION robot to support production demand.
Case Study
Cone Health Enhances IV Automation in the Name of Patient Safety
